What Is NAD+ and Why Your Cells Need It to Age Well

The Molecule Behind Cellular Energy

Every cell in your body depends on a single molecule to convert food into energy, repair damaged DNA, and regulate hundreds of critical processes. That molecule is NAD+ — nicotinamide adenine dinucleotide — and scientists increasingly believe its decline with age may be one of the key drivers of aging itself.

NAD+ is a coenzyme found in every living cell. It acts as an electron shuttle in redox reactions, the chemical exchanges that power mitochondria — the cell's energy factories. Without adequate NAD+, mitochondria falter, energy output drops, and cells begin to malfunction.

More Than Just Fuel

Energy production alone would make NAD+ indispensable, but its role extends far beyond metabolism. According to a comprehensive review in Nature Reviews Molecular Cell Biology, more than 300 enzymes rely on NAD+ to function. These enzymes govern DNA repair, immune response, chromatin remodeling, and cellular senescence — the process by which damaged cells stop dividing.

Two enzyme families are especially dependent on NAD+:

• Sirtuins — a group of seven proteins that regulate gene expression, inflammation, and mitochondrial health. Often called "longevity genes," sirtuins cannot function without NAD+ as a co-substrate.
• PARPs (poly ADP-ribose polymerases) — enzymes that detect and repair DNA breaks. Every time a PARP enzyme fixes a strand of damaged DNA, it consumes one molecule of NAD+.

Why NAD+ Drops With Age

Research published in PMC confirms that NAD+ levels decline steadily across species as organisms age. In humans, this decline has been measured in the brain, liver, skin, skeletal muscle, and blood plasma. By middle age, NAD+ stores may fall by 50% or more compared to youth.

The decline is driven primarily by increased consumption, not decreased production. As the body ages, senescent cells accumulate and trigger immune responses that ramp up NAD+-consuming enzymes — particularly CD38, whose expression rises across multiple tissues. The more NAD+ these enzymes burn through, the less remains available for sirtuins and PARPs to do their protective work.

This creates a vicious cycle: less NAD+ means weaker DNA repair, which produces more damaged cells, which consume even more NAD+.

The Race to Restore NAD+

Scientists have identified several precursor compounds — substances the body can convert into NAD+. The two most studied are nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), both derived from vitamin B3.

A randomized, placebo-controlled trial comparing these precursors in 65 healthy adults found that both NR and NMN at 1,000 mg per day doubled circulating NAD+ levels within 14 days, according to results reported on NMN.com. Multiple clinical trials have found NMN safe at doses up to 1,250 mg per day with no severe adverse events.

However, a critical review in Science Advances cautions that raising NAD+ levels in the blood does not necessarily translate into slower aging or disease prevention. The gap between promising animal studies and definitive human benefits remains wide.

What the Science Says — and Doesn't

In mice, boosting NAD+ has improved mitochondrial function, enhanced stem cell activity, and extended lifespan. Early human trials hint at benefits for insulin sensitivity, sleep quality, and exercise recovery, but these findings are preliminary.

Regulatory waters are also murky. In 2022, the U.S. FDA ruled that NMN could not be marketed as a dietary supplement because it was already under investigation as a pharmaceutical drug — a decision that reshaped the supplement market.

What remains clear is that NAD+ sits at the crossroads of aging biology. Whether boosting it artificially can meaningfully slow human aging is one of the most actively pursued questions in longevity science. For now, the molecule that keeps every cell alive continues to reveal how much we still have to learn about growing old.